ImmunoRestoration is a promising healthcare startup that has been making waves in the field of precision oncology. Established in 2016, the company's mission is to commercialize innovative immunotherapeutic cancer vaccine research that originated at the University of Pennsylvania back in 2004. A thorough evaluation of data from pre-clinical research and studies involving over 100 patients has laid the groundwork for this venture. Recently, in late 2017, ImmunoRestoration, Inc. secured global exclusive rights to market this technology, marking a significant milestone in its journey. With a focus on advancing precision, patient-focused cancer treatment, the company is poised to shape the next chapter in advanced cancer immunotherapy.
General Information
Get notified when ImmunoRestoration moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track ImmunoRestoration
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Health Care
About ImmunoRestoration
Taxonomy: cancer immunotherapy, oncology, precision medicine, cancer vaccine, immunotherapeutic, patient-focused, University of Pennsylvania, drug development, clinical research, innovation, startup, investing, technology commercialization, global exclusive rights
No funding data available for ImmunoRestoration yet.
Get notified when ImmunoRestoration raises fundingImmunoRestoration Alternatives & Competitors
A global cancer community, where researchers contribute and access research tools to accelerate canc...
Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy rese...
Life demands excellence
FAQ About ImmunoRestoration
Don't just browse. Track.
Signal Tracker monitors ImmunoRestoration and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.